Kidney Cancer Clinical Trials
At Moffitt Cancer Center, kidney cancer clinical trials are an integral part of our efforts to improve cancer treatments and the lives of our patients. Clinical trials are studies that explore the effectiveness of new treatments for fighting cancer. In fact, all treatments that are currently considered standard treatments were once available only through clinical trials. We’re on the leading edge of cancer research and work to have a positive impact on the lives of cancer patients – efforts that have resulted in Moffitt being named a Comprehensive Cancer Center by the National Cancer Institute. This designation is not only a recognition of our past accomplishments, but also of our continued efforts to develop new and more effective kidney cancer treatments.
Kidney cancer clinical trials may include:
- Testing new medications
- Developing new surgical techniques
- Exploring new ways of delivering radiation therapy
A patient does not need a referral to consult with our Urologic Oncology Program about participating in one of our clinical trials. There are several factors that are taken into account when determining who is eligible to participate, including age, the type of cancer, general health and any past treatments received. As such, the dynamics of your individual cancer and lifestyle may lead a physician to suggest that you take part in a clinical trial. If so, your physician will discuss with you the details of the particular trial in depth. You can trust that our clinical trials maintain patient health and safety as the top priorities. In fact, new drugs and therapies that are in the clinical trial phase have already gone through rigorous testing to ensure they are safe for use. Additionally, you can opt out at any time. This remains true even if you have already signed a consent form. If you are interested in participating in one of our kidney cancer clinical trials, call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online.
